Research Article
Elevated Midtrimester Triglycerides as a Biomarker for Postpartum Hyperglycemia in Gestational Diabetes
Table 3
Elevated TG levels as a biomarker for the development of postpartum AGM in GDM patients.
| Variables | OR | 95% CI | value |
| TG levels at 24-28 gestational weeks (mmol/L) | | | | Low tertile | Reference | | | Intermediate tertile | 1.120 | 0.597-2.100 | 0.724 | High tertile | 2.001 | 1.054-3.800 | 0.034 | Age (years) | 1.046 | 0.986-1.110 | 0.135 | Prepregnancy BMI (kg/m2) | 0.980 | 0.896-1.072 | 0.661 | Family history of DM | 1.007 | 0.550-1.841 | 0.983 | Insulin treatment during pregnancy | 1.460 | 0.816-2.611 | 0.202 | FPG at 24-28 gestational weeks (mmol/L) | 0.852 | 0.570-1.275 | 0.437 | HbA1c at 24-28 gestational weeks (%) | 2.738 | 1.415-5.299 | 0.003 | Macrosomia | 1.011 | 0.380-2.691 | 0.983 | ALT at 24-28 gestational weeks (U/L) | 0.985 | 0.953-1.018 | 0.371 | AST at 24-28 gestational weeks (U/L) | 1.019 | 0.978-1.061 | 0.368 |
|
|
TG: triglyceride; DM: diabetes mellitus; BMI: body mass index; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c; ALT: alanine aminotransferase; AST: aspartate aminotransferase.
|